In summary, we provide a schematic diagram to help illustrate the detailed mechanism of fumrate induced MIR4435-2HG expression and MIR4435-2HG/STAT1/GLS1 signal pathway in FH-deficient RCC, and GLS1 inhibitor might serve as a promising therapeutic target (Fig. 6). This evidence concerns the gene STAT1 and renal cell carcinoma.